DaVita (BSP:DVAI34) Pre-Tax Income : R$5,835 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is DaVita Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. DaVita's pretax income for the three months ended in Dec. 2023 was R$1,416 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was R$5,835 Mil. DaVita's pretax margin was 9.19%.

During the past 13 years, DaVita's highest Pretax Margin was 15.16%. The lowest was 6.90%. And the median was 10.37%.

DaVita Pre-Tax Income Historical Data

The historical data trend for DaVita's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Pre-Tax Income Chart

DaVita Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

4,906.68

6,782.06

8,586.93

5,068.52

5,767.53

DaVita Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															773.66	1,117.89	1,432.79	1,867.86	1,416.37

Competitive Comparison of DaVita's Pre-Tax Income

For the Medical Care Facilities subindustry, DaVita's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DaVita's Pre-Tax Income Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where DaVita's Pre-Tax Income falls into.

DaVita Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

DaVita's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	7844.594	+	-124.249	+	-1952.82	+	0	+	-9.0949470177293E-13
	=	5,768

DaVita's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	2012.005	+	-124.323	+	-471.312	+	0	+	-2.2737367544323E-13
	=	1,416

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$5,835 Mil.

DaVita (BSP:DVAI34) Pre-Tax Income Explanation

DaVita's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	1416.37	/	15413.531
	=	9.19%

During the past 13 years, DaVita's highest Pretax Margin was 15.16%. The lowest was 6.90%. And the median was 10.37%.

DaVita Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of DaVita's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

DaVita (BSP:DVAI34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (BSP:DVAI34) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

DVA:USA TRL:Germany

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (BSP:DVAI34) Headlines

No Headlines